Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Ahmad, Ata Ul Wakeel (1) Bähring, Sylvia Dr. (1) Bartels-Klein, Eireen (1) Chu, Van Trung Dr. (3) Dechend, Ralf Priv. Doz. (1) de la Rosa, Kathrin Dr. (22) Gerhard, Cathrin (2) Gerhardt, Holger Prof. Dr. (1) Graf, Robin Dr. (1) Haase, Nadine Dr. (1) Herse, Florian PD Dr. (1) Hodge, Russell (2) Hollfinger, Irene (1) Hübner, Norbert Prof. Dr. (1) Ittermann, Bernd Dr. (2) Janke, Jürgen Dr. (1) Jeuthe, Sarah Dr. (1) Kettritz, Ralph Prof. Dr. (1) Klix, Sabrina (1) Klußmann, Enno PD Dr. (1) Kocks, Christine Dr. (2) Kräker, Kristin Dr. (1) Ku, Min-Chi Dr. (1) Kühn, Ralf Dr. (3) Luft, Friedrich Prof. Dr. (18) Marko, Lajos Dr. (1) Moreno Velásquez, Ilais Dr. (1) Müller, Dominik Prof. Dr. (2) Niendorf, Thoralf Prof. Dr. (32) Obermayer-Wasserscheid, Benedikt Dr. (1) Paul, Friedemann Prof. Dr. med. (2) Perrot, Andreas (2) Pilz, Bernhard Dr. (4) Pischon, Tobias Prof. Dr. (4) Rajewsky, Klaus Prof. Dr. (4) Reimann, Henning Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (268) Silvis, Casper (1) Spatt, Lisa (3) Spuler, Simone Prof. (6) Vazquez Garcia, Clara (4) Waiczies, Helmar Dr. (3) Waiczies, Sonia PD Dr. (2) Wilck, Nicola Dr. med. (1) Winter, Lukas Dr. (7) Zach, Andreas (1) (-) Lebedin, Mikhail (8) Biobank (1) Genom-Editierung & Krankheitsmodelle (4) Hochschulambulanz für Neuroimmunologie (1) (-) Immunmechanismen und humane Antikörper (8) Immunregulation und Krebs (3) Molekulare Epidemiologie (1) Transgenics (4) Translational Bioinformatics (1) 2021 (1) 2022 (2) 2023 (3) 2024 (2) 8 Ergebnisse: Active Filter: Lebedin, MikhailImmunmechanismen und humane Antikörper Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Februar 2024 / Sci Immunol Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis X. Li T. Wirtz T. Weber M. Lebedin E.D. Lowenstein T. Sommermann A. Zach T. Yasuda K. de la Rosa V.T. Chu J.H. Schulte I. Müller C. Kocks K. Rajewsky 15. März 2024 / iScience Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses M. Lebedin C. Ratswohl A. Garg M. Schips C. Vazquez Garcia L. Spatt C. Thibeault B. Obermayer J. Weiner I. Moreno Velásquez C. Gerhard P. Stubbemann L.G. Hanitsch T. Pischon M. Witzenrath L.E. Sander F. Kurth M. Meyer-Hermann K. de la Rosa 01. Januar 2021 / Open Biol A homology independent sequence replacement strategy in human cells using a CRISPR nuclease E. Danner M. Lebedin K. de la Rosa R. Kühn 03. Juni 2022 / Sci Adv Precise CRISPR/Cas-mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells N.T. Tran E. Danner X. Li R. Graf M. Lebedin K. de la Rosa R. Kühn K. Rajewsky V.T. Chu 06. September 2022 / Proc Natl Acad Sci U S A Different classes of genomic inserts contribute to human antibody diversity M. Lebedin M. Foglierini S. Khorkova C. Vázquez García C. Ratswohl A.N. Davydov M.A. Turchaninova C. Daubenberger D.M. Chudakov A. Lanzavecchia K. de la Rosa 20. April 2023 / Bio-protocol Application of a spacer-nick gene-targeting approach to repair disease-causing mutations with increased safety N.T. Tran M. Lebedin E. Danner R. Kühn K. Rajewsky V.T. Chu 01. Oktober 2023 / Eur J Immunol A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses C. Ratswohl C. Vázquez García A.U.W. Ahmad H. Gonschior M. Lebedin C.E. Silvis L. Spatt C. Gerhard M. Lehmann L.E. Sander F. Kurth S. Olsson K. de la Rosa 01. Mai 2023 / Eur J Immunol Discriminating promiscuous from target-specific autoantibodies in COVID-19 M. Lebedin C. Vazquez Garcia L. Spatt C. Ratswohl C. Thibeault L. Ostendorf T. Alexander F. Paul L.E. Sander F. Kurth K. de la Rosa
02. Februar 2024 / Sci Immunol Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis X. Li T. Wirtz T. Weber M. Lebedin E.D. Lowenstein T. Sommermann A. Zach T. Yasuda K. de la Rosa V.T. Chu J.H. Schulte I. Müller C. Kocks K. Rajewsky
15. März 2024 / iScience Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses M. Lebedin C. Ratswohl A. Garg M. Schips C. Vazquez Garcia L. Spatt C. Thibeault B. Obermayer J. Weiner I. Moreno Velásquez C. Gerhard P. Stubbemann L.G. Hanitsch T. Pischon M. Witzenrath L.E. Sander F. Kurth M. Meyer-Hermann K. de la Rosa
01. Januar 2021 / Open Biol A homology independent sequence replacement strategy in human cells using a CRISPR nuclease E. Danner M. Lebedin K. de la Rosa R. Kühn
03. Juni 2022 / Sci Adv Precise CRISPR/Cas-mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells N.T. Tran E. Danner X. Li R. Graf M. Lebedin K. de la Rosa R. Kühn K. Rajewsky V.T. Chu
06. September 2022 / Proc Natl Acad Sci U S A Different classes of genomic inserts contribute to human antibody diversity M. Lebedin M. Foglierini S. Khorkova C. Vázquez García C. Ratswohl A.N. Davydov M.A. Turchaninova C. Daubenberger D.M. Chudakov A. Lanzavecchia K. de la Rosa
20. April 2023 / Bio-protocol Application of a spacer-nick gene-targeting approach to repair disease-causing mutations with increased safety N.T. Tran M. Lebedin E. Danner R. Kühn K. Rajewsky V.T. Chu
01. Oktober 2023 / Eur J Immunol A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses C. Ratswohl C. Vázquez García A.U.W. Ahmad H. Gonschior M. Lebedin C.E. Silvis L. Spatt C. Gerhard M. Lehmann L.E. Sander F. Kurth S. Olsson K. de la Rosa
01. Mai 2023 / Eur J Immunol Discriminating promiscuous from target-specific autoantibodies in COVID-19 M. Lebedin C. Vazquez Garcia L. Spatt C. Ratswohl C. Thibeault L. Ostendorf T. Alexander F. Paul L.E. Sander F. Kurth K. de la Rosa